泰格医药
(300347)
| 流通市值：305.14亿 | | | 总市值：462.92亿 |
| 流通股本：5.70亿 | | | 总股本：8.65亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,055,344,830.04 | 1,967,632,936.81 | 3,172,620,470.07 | 7,441,511,431.55 |
| 应收票据及应收账款 | 1,365,768,881.61 | 1,244,919,487.1 | 1,346,556,781.14 | 1,209,958,775.51 |
| 其中：应收票据 | 6,010,700.41 | 3,674,560 | 13,644,901.84 | 793,924 |
| 应收账款 | 1,359,758,181.2 | 1,241,244,927.1 | 1,332,911,879.3 | 1,209,164,851.51 |
| 预付款项 | 101,932,971.27 | 119,048,268.73 | 86,532,181.89 | 70,577,022.81 |
| 其他应收款合计 | 89,030,886.84 | 102,962,088.09 | 105,960,575.94 | 84,391,459.71 |
| 其中:应收利息 | - | 16,771,156.69 | 17,376,536.37 | 22,508,577.43 |
| 存货 | 31,956,085.52 | 22,196,124.75 | 22,136,941 | 23,674,382.97 |
| 合同资产 | 2,504,689,617.5 | 2,940,514,164.81 | 2,811,792,918.88 | 2,760,959,510.07 |
| 其他流动资产 | 76,108,977.92 | 73,947,764.66 | 58,517,272.05 | 61,896,842.73 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 6,299,685,225.86 | 6,547,520,834.95 | 7,646,634,878.7 | 11,661,670,938.83 |
| 非流动资产: | | | | |
| 长期股权投资 | 3,424,603,314.72 | 3,515,279,694.87 | 3,518,375,411.56 | 2,977,436,177.65 |
| 其他权益工具投资 | 8,090,146.65 | 10,629,739.38 | 9,872,440.95 | 13,746,806.84 |
| 其他非流动金融资产 | 10,105,905,487.26 | 10,716,445,742.86 | 10,497,204,889.49 | 10,368,445,725.18 |
| 固定资产 | 778,498,376.24 | 584,711,474.52 | 608,338,138.68 | 619,257,434.8 |
| 在建工程 | 420,535,374.37 | 516,620,831.31 | 472,627,690.59 | 407,763,268.49 |
| 使用权资产 | 487,230,305.93 | 509,187,439.2 | 456,868,986.13 | 475,650,873.31 |
| 无形资产 | 336,876,524.01 | 325,329,299.93 | 345,000,363.85 | 349,319,712.91 |
| 商誉 | 3,227,762,493.75 | 2,810,082,693.5 | 2,799,342,027.04 | 2,807,161,549.83 |
| 长期待摊费用 | 210,094,767.04 | 189,271,411.97 | 197,936,926.37 | 206,813,517.24 |
| 递延所得税资产 | 126,686,732.61 | 131,375,915.05 | 123,325,371.64 | 144,070,965.98 |
| 其他非流动资产 | 3,245,047,038.72 | 4,420,136,943.76 | 3,741,589,284.84 | 38,848,520.11 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 22,371,330,561.3 | 23,729,071,186.35 | 22,770,481,531.14 | 18,408,514,552.34 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 28,671,015,787.16 | 30,276,592,021.3 | 30,417,116,409.84 | 30,070,185,491.17 |
| 流动负债: | | | | |
| 短期借款 | 1,912,017,204.22 | 3,010,434,835 | 2,767,059,200 | 2,278,596,600 |
| 应付票据及应付账款 | 257,287,412.33 | 229,928,730.46 | 230,511,814.45 | 257,404,089.36 |
| 其中：应付票据 | - | 1,598,000 | 3,399,000 | 2,600,000 |
| 应付账款 | 257,287,412.33 | 228,330,730.46 | 227,112,814.45 | 254,804,089.36 |
| 合同负债 | 790,737,308.84 | 809,815,727.76 | 772,245,863.28 | 767,183,050.39 |
| 应付职工薪酬 | 243,974,190.43 | 165,533,781.62 | 233,446,905.33 | 384,320,213.64 |
| 应交税费 | 159,172,131.01 | 174,553,344.24 | 158,161,687.49 | 152,291,187.89 |
| 其他应付款合计 | 76,840,278.73 | 83,945,580.68 | 594,905,642.35 | 76,497,812.57 |
| 其中:应付利息 | 5,310,915.46 | 3,620,817.53 | 6,898,997.92 | 3,273,703.82 |
| 应付股利 | 2,609,775.37 | 1,823,888.87 | 513,481,650.41 | 1,842,314.05 |
| 一年内到期的非流动负债 | 198,600,777.18 | 299,686,178.53 | 555,727,450.13 | 527,336,071.49 |
| 其他流动负债 | 23,223,162.38 | 21,359,578.54 | 20,357,240.08 | 20,285,472.37 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 3,661,852,465.12 | 4,795,257,756.83 | 5,332,415,803.11 | 4,463,914,497.71 |
| 非流动负债: | | | | |
| 长期借款 | 323,649,635.25 | 397,237,083.72 | 404,817,974.35 | 434,746,054.63 |
| 租赁负债 | 399,316,716.16 | 444,120,824.43 | 386,754,553.73 | 407,493,028.57 |
| 长期应付职工薪酬 | 2,784,565.42 | 2,441,425.78 | 2,476,446.05 | 2,415,367.7 |
| 递延收益 | 17,136,295.72 | 14,111,379.63 | 14,462,985.38 | 14,509,115.06 |
| 递延所得税负债 | 201,796,922.9 | 204,624,399.71 | 208,712,497.33 | 213,815,553 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 944,684,135.45 | 1,062,535,113.27 | 1,017,224,456.84 | 1,072,979,118.96 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 4,606,536,600.57 | 5,857,792,870.1 | 6,349,640,259.95 | 5,536,893,616.67 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 864,948,570 | 864,948,570 | 864,948,570 | 872,418,220 |
| 资本公积 | 10,772,578,438.11 | 10,780,324,919.18 | 10,776,919,164.02 | 11,586,387,608.94 |
| 减:库存股 | 191,146,104.89 | 191,146,104.89 | 180,796,021.11 | 869,336,804.33 |
| 其他综合收益 | 99,095,699.24 | 77,377,043.56 | 91,214,186.82 | 95,964,416.54 |
| 盈余公积 | 436,529,393.76 | 436,529,393.76 | 436,529,393.76 | 436,529,393.76 |
| 未分配利润 | 8,688,647,453.5 | 9,096,932,877.14 | 8,776,352,812.65 | 9,009,866,752.14 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 20,670,653,449.72 | 21,064,966,698.75 | 20,765,168,106.14 | 21,131,829,587.05 |
| 少数股东权益 | 3,393,825,736.87 | 3,353,832,452.45 | 3,302,308,043.75 | 3,401,462,287.45 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 24,064,479,186.59 | 24,418,799,151.2 | 24,067,476,149.89 | 24,533,291,874.5 |
| 负债和股东权益合计 | 28,671,015,787.16 | 30,276,592,021.3 | 30,417,116,409.84 | 30,070,185,491.17 |
| 公告日期 | 2025-03-28 | 2024-10-30 | 2024-08-29 | 2024-04-26 |
| 审计意见(境内) | 标准无保留意见 | | | |